PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 122 filers reported holding PMV PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,413,122 | +55.6% | 2,347,414 | +58.6% | 0.03% | +62.5% |
Q2 2023 | $9,263,968 | +40.6% | 1,479,867 | +7.1% | 0.02% | +6.7% |
Q1 2023 | $6,588,940 | -45.3% | 1,381,329 | -0.3% | 0.02% | -68.1% |
Q4 2022 | $12,051,823 | -33.2% | 1,385,267 | -8.7% | 0.05% | -19.0% |
Q3 2022 | $18,055,000 | -16.6% | 1,517,246 | -0.2% | 0.06% | 0.0% |
Q2 2022 | $21,659,000 | -35.0% | 1,519,935 | -5.0% | 0.06% | -13.4% |
Q1 2022 | $33,303,000 | -9.9% | 1,599,553 | 0.0% | 0.07% | -1.5% |
Q4 2021 | $36,949,000 | -12.7% | 1,599,553 | +12.7% | 0.07% | -4.2% |
Q3 2021 | $42,303,000 | +9.8% | 1,419,553 | +25.9% | 0.07% | +24.6% |
Q2 2021 | $38,513,000 | +3.7% | 1,127,418 | -0.2% | 0.06% | +3.6% |
Q1 2021 | $37,155,000 | -46.4% | 1,129,681 | +0.2% | 0.06% | -51.3% |
Q4 2020 | $69,331,000 | +311.1% | 1,127,151 | +137.3% | 0.11% | +264.5% |
Q3 2020 | $16,863,000 | – | 475,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $19,217,000 | 59.24% |
Euclidean Capital LLC | 2,336,909 | $27,809,000 | 25.82% |
OUP Management Co., LLC | 989,232 | $11,772,000 | 18.33% |
Nextech Invest Ltd. | 1,385,807 | $16,491,000 | 5.33% |
Boxer Capital, LLC | 3,163,795 | $37,649,000 | 2.12% |
PERSONAL CFO SOLUTIONS, LLC | 550,342 | $6,549,000 | 1.64% |
Orbimed Advisors | 6,563,077 | $78,101,000 | 1.45% |
RTW INVESTMENTS, LP | 4,356,920 | $51,847,000 | 1.20% |
ACUTA CAPITAL PARTNERS, LLC | 154,500 | $1,839,000 | 0.79% |
Monarch Partners Asset Management LLC | 210,370 | $2,503,000 | 0.75% |